Cargando…

Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial

INTRODUCTION: Persistent physical symptoms (PPS), also known as medically unexplained symptoms are associated with profound physical disability, psychological distress and high healthcare costs. England’s annual National Health Service costs of attempting to diagnose and treat PPS amounts to approxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Meenal, James, Kirsty, Moss-Morris, Rona, Husain, Mujtaba, Ashworth, Mark, Frank, Philipp, Ferreira, Nicola, Mosweu, Iris, McCrone, Paul, Hotopf, Matthew, David, Anthony, Landau, Sabine, Chalder, Trudie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661663/
https://www.ncbi.nlm.nih.gov/pubmed/31340956
http://dx.doi.org/10.1136/bmjopen-2018-025513
_version_ 1783439496899985408
author Patel, Meenal
James, Kirsty
Moss-Morris, Rona
Husain, Mujtaba
Ashworth, Mark
Frank, Philipp
Ferreira, Nicola
Mosweu, Iris
McCrone, Paul
Hotopf, Matthew
David, Anthony
Landau, Sabine
Chalder, Trudie
author_facet Patel, Meenal
James, Kirsty
Moss-Morris, Rona
Husain, Mujtaba
Ashworth, Mark
Frank, Philipp
Ferreira, Nicola
Mosweu, Iris
McCrone, Paul
Hotopf, Matthew
David, Anthony
Landau, Sabine
Chalder, Trudie
author_sort Patel, Meenal
collection PubMed
description INTRODUCTION: Persistent physical symptoms (PPS), also known as medically unexplained symptoms are associated with profound physical disability, psychological distress and high healthcare costs. England’s annual National Health Service costs of attempting to diagnose and treat PPS amounts to approximately £3 billion. Current treatment relies on a positive diagnosis, life-style advice and drug therapy. However, many patients continue to suffer from ongoing symptoms and general practitioners (GPs) are challenged to find effective treatments. Training GPs in basic cognitive behavioural skills and providing self-help materials to patients could be useful, but availability in primary care settings is limited. METHODS AND ANALYSIS: A cluster randomised waiting list, controlled trial will be conducted to assess the feasibility of an integrated approach to care in general practice. Approximately 240 patients with PPS will be recruited from 8 to 12 GP practices in London. GP practices will be randomised to ‘integrated GP care plus treatment as usual’ or waiting list control. Integrated GP care plus treatment as usual will include GP training in cognitive behavioural skills, GP supervision and written and audio visual materials for both GPs and participants. The primary objectives will be assessment of trial and intervention feasibility. Secondary objectives will include estimating the intracluster correlation coefficient for potential outcome measures for cluster effects in a sample size calculation. Feasibility parameters and identification of suitable primary and secondary outcomes for future trial evaluations will be assessed prerandomisation and at 12 and 24 weeks’ postrandomisation, using a mixed-methods approach. ETHICS AND DISSEMINATION: Ethical approval was granted by the Camberwell St Giles Ethics Committee. Results will be disseminated via peer-reviewed publications and conference presentations. This trial will inform researchers, clinicians, patients and healthcare providers about the feasibility and potential cost-effectiveness of an integrated approach to managing PPS in primary care. TRIAL REGISTRATION NUMBER: NCT02444520; Pre-results.
format Online
Article
Text
id pubmed-6661663
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66616632019-08-07 Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial Patel, Meenal James, Kirsty Moss-Morris, Rona Husain, Mujtaba Ashworth, Mark Frank, Philipp Ferreira, Nicola Mosweu, Iris McCrone, Paul Hotopf, Matthew David, Anthony Landau, Sabine Chalder, Trudie BMJ Open Public Health INTRODUCTION: Persistent physical symptoms (PPS), also known as medically unexplained symptoms are associated with profound physical disability, psychological distress and high healthcare costs. England’s annual National Health Service costs of attempting to diagnose and treat PPS amounts to approximately £3 billion. Current treatment relies on a positive diagnosis, life-style advice and drug therapy. However, many patients continue to suffer from ongoing symptoms and general practitioners (GPs) are challenged to find effective treatments. Training GPs in basic cognitive behavioural skills and providing self-help materials to patients could be useful, but availability in primary care settings is limited. METHODS AND ANALYSIS: A cluster randomised waiting list, controlled trial will be conducted to assess the feasibility of an integrated approach to care in general practice. Approximately 240 patients with PPS will be recruited from 8 to 12 GP practices in London. GP practices will be randomised to ‘integrated GP care plus treatment as usual’ or waiting list control. Integrated GP care plus treatment as usual will include GP training in cognitive behavioural skills, GP supervision and written and audio visual materials for both GPs and participants. The primary objectives will be assessment of trial and intervention feasibility. Secondary objectives will include estimating the intracluster correlation coefficient for potential outcome measures for cluster effects in a sample size calculation. Feasibility parameters and identification of suitable primary and secondary outcomes for future trial evaluations will be assessed prerandomisation and at 12 and 24 weeks’ postrandomisation, using a mixed-methods approach. ETHICS AND DISSEMINATION: Ethical approval was granted by the Camberwell St Giles Ethics Committee. Results will be disseminated via peer-reviewed publications and conference presentations. This trial will inform researchers, clinicians, patients and healthcare providers about the feasibility and potential cost-effectiveness of an integrated approach to managing PPS in primary care. TRIAL REGISTRATION NUMBER: NCT02444520; Pre-results. BMJ Publishing Group 2019-07-23 /pmc/articles/PMC6661663/ /pubmed/31340956 http://dx.doi.org/10.1136/bmjopen-2018-025513 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Patel, Meenal
James, Kirsty
Moss-Morris, Rona
Husain, Mujtaba
Ashworth, Mark
Frank, Philipp
Ferreira, Nicola
Mosweu, Iris
McCrone, Paul
Hotopf, Matthew
David, Anthony
Landau, Sabine
Chalder, Trudie
Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title_full Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title_fullStr Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title_full_unstemmed Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title_short Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
title_sort persistent physical symptoms reduction intervention: a system change and evaluation (prince)—integrated gp care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661663/
https://www.ncbi.nlm.nih.gov/pubmed/31340956
http://dx.doi.org/10.1136/bmjopen-2018-025513
work_keys_str_mv AT patelmeenal persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT jameskirsty persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT mossmorrisrona persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT husainmujtaba persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT ashworthmark persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT frankphilipp persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT ferreiranicola persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT mosweuiris persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT mccronepaul persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT hotopfmatthew persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT davidanthony persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT landausabine persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial
AT chaldertrudie persistentphysicalsymptomsreductioninterventionasystemchangeandevaluationprinceintegratedgpcareforpersistentphysicalsymptomsprotocolforafeasibilityandclusterrandomisedwaitinglistcontrolledtrial